What are Ocular Therapeutix's profit margins?

Ocular Therapeutix (OCUL) runs a 87.2% gross margin and a -575.4% operating margin, with a -558.2% net margin.

Where do Ocular Therapeutix's ratios come from?

Every ratio is computed from Ocular Therapeutix's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Ocular Therapeutix OCUL Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Gross margin	87.2%-0.1pp	87.3%-1.5pp	88.9%-0.5pp	89.4%-1.3pp	90.7%-0.5pp
Operating margin	-575.4%-55.7pp	-519.8%-70.1pp	-449.7%-47.1pp	-402.6%-60.5pp	-342.2%-72.6pp
Net margin	-558.2%-46.3pp	-511.9%-64.3pp	-447.6%-65.1pp	-382.5%-59.4pp	-323.1%-19.4pp
Returns
Return on equity	-68.6%-13.7pp	-54.9%+27.0pp	-81.8%-18.4pp	-63.4%-6.2pp	-57.2%+38.0pp
Efficiency
Asset turnover	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×-0.1×
Liquidity
Current ratio	14.8×-0.6×	15.4×+7.5×	7.9×-2.2×	10.1×-0.1×	10.2×-0.4×
Leverage
Debt-to-equity	0.1×0.0×	0.1×-0.2×	0.3×0.0×	0.3×0.0×	0.3×0.0×
Per Share
Book value per share	$2.60-25.7%	$3.49+149%	$1.40-20.8%	$1.77+12.9%	$1.57-21.2%
Valuation
Market capitalization	$1.84B-28.7%	$2.59B+27.2%	$2.03B+40.5%	$1.45B+24.2%	$1.17B-13.2%
Price / sales	35.4×-14.4×	49.8×+13.3×	36.5×+10.9×	25.6×+6.0×	19.5×-1.5×
Price / book	3.2×-0.8×	4×-3.9×	7.9×+3.1×	4.7×+0.4×	4.4×+0.1×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Ocular Therapeutix's profit margins?: Ocular Therapeutix (OCUL) runs a 87.2% gross margin and a -575.4% operating margin, with a -558.2% net margin.
Where do Ocular Therapeutix's ratios come from?: Every ratio is computed from Ocular Therapeutix's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.